Bronchitis pill results `better than expected'
Wednesday 13 August 1997
Glen Travers, Cortecs chief executive, said patients taking the pill, called Pseudostat, in phase II trials had 10 times fewer bouts of infection than those on dummy pills in the five months after treatment ended. "Pseudostat is quite impressive. We have a unique product that can deal with a respiratory disease that hasn't been adequately treated with other medicines," Mr Travers said.
Analysts were cautiously optimistic. Stewart Adkins of Lehman Brothers said: "These results look very positive. The key is whether people on this drug need to use less antibiotic. But if these results indicate that Cortecs' oral vaccine technology works, it could be quite significant."
Mr Travers said the company would begin final-stage clinical trials of Pseudostat this year and would file for registration in Europe in 1998. "That is aggressive, but we really plan to push this drug," he said.
Chronic bronchitis, a bacterial lung infection responsible for 5 per cent of all deaths in the UK, is treated with antibiotics and often involves hospitalisation. Mr Travers said patients taking Pseudostat needed to take less antibiotic and of the 91 sufferers tested, none taking Pseudostat needed to be hospitalised.
Commenting on the recent share price weakness, which followed Cortecs' presentation in May of crucial final-stage data on its lead pill to treat brittle bones, Macritonin, Mr Travers said: "We don't feel any nervousness about that trial."
- 1 Man on naked bike ride gets ejected after becoming aroused
- 3 Ann Summers survey reveals the UK's favourite sex position
- 4 Jaden Smith wears gender fluid dress to high school prom with Hunger Games actress
- 5 How much sex should I be having?
Ed Miliband returns to the backbenches but it's all a bit awkward as he tries to avoid eye-contact with fellow Labour MPs
Man on naked bike ride gets ejected after becoming aroused
Charles Kennedy 1959-2015: A gifted, compassionate politician whose career was cut short by the 'demon drink' - latest news
Ayyan Ali: Pakistan's top model now appears in the courtroom rather than on the catwalk
Isis tortures 14-year-old Syrian boy and films it in graphic video for 'propaganda purposes'
Migrants in Kos: Photos show real tragedy after Brits abroad complain of 'awkward' holidays
Thousands of teenage girls enduring debilitating illnesses after routine school cancer vaccination
British tourists complain that impoverished boat migrants are making holidays 'awkward' in Kos
Michael Gove determined to scrap the Human Rights Act – even if Scotland retains it
Threat to scrap Human Rights Act could see UK follow Nazi example, warns UN official
Why this year's general election was the most unfair in Britain's history
iJobs Money & Business
£30000 - £35000 per annum: Recruitment Genius: The UK's fastest growing, multi...
£70000 - £90000 per annum: Recruitment Genius: A Financial Reporting Manager i...
£23000 - £25000 per annum: Recruitment Genius: They win lots of awards for the...
£13500 - £20000 per annum: Recruitment Genius: This nationwide enforcement com...